Baum RP - Search Results

1

Joint EANM/SNMMI procedure guideline for the use of ¹⁷⁷Lu-labeled PSMA-targeted radioligand-therapy (¹⁷⁷Lu-PSMA-RLT).

Kratochwil C, Fendler WP, Eiber M, Hofman MS, Emmett L, Calais J, Osborne JR, Iravani A, Koo P, Lindenberg L, Baum RP, Bozkurt MF, Delgado Bolton RC, Ezziddin S, Forrer F, Hicks RJ, Hope TA, Kabasakal L, Konijnenberg M, Kopka K, Lassmann M, Mottaghy FM, Oyen WJG, Rahbar K, Schoder H, Virgolini I, Bodei L, Fanti S, Haberkorn U, Hermann K. Kratochwil C, et al. Among authors: baum rp. Eur J Nucl Med Mol Imaging. 2023 Jul;50(9):2830-2845. doi: 10.1007/s00259-023-06255-8. Epub 2023 May 29. Eur J Nucl Med Mol Imaging. 2023. PMID: 37246997 Free PMC article.

2

Rapid Tumor Washout of 177 Lu-PSMA Radioligand in Renal Cell Carcinoma.

Zhang J, Schuchardt C, Chen X, Baum RP. Zhang J, et al. Among authors: baum rp. Clin Nucl Med. 2023 Aug 1;48(8):732-734. doi: 10.1097/RLU.0000000000004725. Epub 2023 Jun 3. Clin Nucl Med. 2023. PMID: 37276536

3

Extended peptide receptor radionuclide therapy: evaluating nephrotoxicity and therapeutic effectiveness in neuroendocrine tumor patients receiving more than four treatment cycles.

Baum RP, Fan X, Jakobsson V, Schuchardt C, Chen X, Yu F, Zhang J. Baum RP, et al. Eur J Nucl Med Mol Imaging. 2024 Mar;51(4):1136-1146. doi: 10.1007/s00259-023-06544-2. Epub 2023 Dec 2. Eur J Nucl Med Mol Imaging. 2024. PMID: 38040931

4

Case Report: Long-term complete response to PSMA-targeted radioligand therapy and abiraterone in a metastatic prostate cancer patient.

Parker D, Zambelli J, Lara MK, Wolf TH, McDonald A, Lee E, Abou-Elkacem L, Gordon EJ, Baum RP. Parker D, et al. Among authors: baum rp. Front Oncol. 2023 Apr 28;13:1192792. doi: 10.3389/fonc.2023.1192792. eCollection 2023. Front Oncol. 2023. PMID: 37188199 Free PMC article.

5

Celebrating 80 years anniversary of radioiodine for use in thyroid cancer and perspectives for theranostics.

Hertz B, Watabe T, Baum RP. Hertz B, et al. Among authors: baum rp. Ann Nucl Med. 2022 Dec;36(12):1007-1009. doi: 10.1007/s12149-022-01806-9. Epub 2022 Nov 8. Ann Nucl Med. 2022. PMID: 36346502

6

Alpha-peptide receptor radionuclide therapy using actinium-225 labeled somatostatin receptor agonists and antagonists.

Shi M, Jakobsson V, Greifenstein L, Khong PL, Chen X, Baum RP, Zhang J. Shi M, et al. Among authors: baum rp. Front Med (Lausanne). 2022 Dec 7;9:1034315. doi: 10.3389/fmed.2022.1034315. eCollection 2022. Front Med (Lausanne). 2022. PMID: 36569154 Free PMC article. Review.

7

Editorial: Targeted alpha particle therapy in oncology.

Bruland ØS, Larsen RH, Baum RP, Juzeniene A. Bruland ØS, et al. Among authors: baum rp. Front Med (Lausanne). 2023 Mar 7;10:1165747. doi: 10.3389/fmed.2023.1165747. eCollection 2023. Front Med (Lausanne). 2023. PMID: 36960341 Free PMC article. No abstract available.

8

3BP-3940, a highly potent FAP-targeting peptide for theranostics - production, validation and first in human experience with Ga-68 and Lu-177.

Greifenstein L, Gunkel A, Hoehne A, Osterkamp F, Smerling C, Landvogt C, Mueller C, Baum RP. Greifenstein L, et al. Among authors: baum rp. iScience. 2023 Nov 23;26(12):108541. doi: 10.1016/j.isci.2023.108541. eCollection 2023 Dec 15. iScience. 2023. PMID: 38089587 Free PMC article.

9

Long-term Nephrotoxicity after PRRT: Myth or Reality.

Baum RP, Fan X, Jakobsson V, Yu F, Schuchardt C, Chen X, Zhang J. Baum RP, et al. Theranostics. 2024 Jan 1;14(2):451-459. doi: 10.7150/thno.92487. eCollection 2024. Theranostics. 2024. PMID: 38169589 Free PMC article.

10

Guiding principles on the education and practice of theranostics.

Pascual TNB, Paez D, Iagaru A, Gnanasegaran G, Lee ST, Sathekge M, Buatti JM, Giammarile F, Al-Ibraheem A, Pardo MA, Baum RP, De Bari B, Ben-Haim S, Blay JY, Brink A, Estrada-Lobato E, Fanti S, Golubic AT, Hatazawa J, Israel O, Kiess A, Knoll P, Louw L, Mariani G, Mirzaei S, Orellana P, Prior JO, Urbain JL, Vichare S, Vinjamuri S, Virgolini I, Scott AM. Pascual TNB, et al. Among authors: baum rp. Eur J Nucl Med Mol Imaging. 2024 Mar 8. doi: 10.1007/s00259-024-06657-2. Online ahead of print. Eur J Nucl Med Mol Imaging. 2024. PMID: 38453729

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

324 results

Search Page